Navigation Links
China-Biotics Appoints New Chief Operating Officer
Date:11/11/2010

SHANGHAI, Nov. 11, 2010 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. ("China-Biotics" or "the Company"), (Nasdaq: CHBT) the leading developer, manufacturer and distributor of probiotics products in China, today announced the appointment of Dr. Hui S. Chang as Chief Operating Officer, effective immediately.

Dr. Chang brings 15 years of biopharmaceutical project management experience and excellent research capabilities. Prior to joining China-Biotics, Dr. Chang served as the president of a consulting service for a Sino-U.S. joint biopharmaceutical program, where he led the scientific design, development, clinical trials, production and quality control for viral vaccines and antibodies. He reported to the State Administration of Foreign Experts Affairs and played a key role in generating profits on the completed contract. Dr. Chang was previously a senior manager of Nabi Biopharmaceuticals, where he supervised the development and production of bacterial and viral vaccines, developed biological potency and immunological methods and managed the development of assays for quality control and clinical testing. Earlier, Dr. Chang served as a manager at Vaccinnate, a North American bio-vaccine company, where he led the design, GMP production and clinical testing of viral vaccines. Previously, Dr. Chang was a research scientist with Cambridge Biotech, where he specialized in the production and quality control of monoclonal biological products, protein products as well as HIV and HTLV antigen. Dr. Chang started his professional career at North AM VAC Inc. in 1989.

Dr. Chang holds a Ph.D. in vaccine development focusing on biochemistry and immunology as well as an MBA with concentration in finance and logistics in the vaccine industry from Johns Hopkins University. He also has a Bachelor of Science in biology from the University of Maryland. Dr. Chang has also received certified training in Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Good Manufacturing Practice (GMP) and Good Safety Practice (GSP) procedures. Dr. Chang is fluent in English and mandarin Chinese.

Mr. Jinan Song, Chairman and CEO of China-Biotics, commented, "We are very pleased that China-Biotics has been able to attract such a qualified candidate for this crucial position. Dr. Chang's solid biotech background, advanced project management track record, and his excellent knowledge in business and finance will make him a strong COO and desirable addition to our team. China-Biotics continues to build a strong management team to support our expanding bulk business in both the dairy and animal feed markets in China."

About China-BioticsChina-Biotics, Inc. ("China-Biotics" or "the Company"), a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements in China. Through its wholly owned subsidiaries, Shanghai Shining Biotechnology Co., Ltd. and Growing Bioengineering (Shanghai) Co. Ltd., the Company develops and produces its proprietary product portfolio. Currently, the retail products are sold OTC mainly through large distributors to pharmacies and supermarkets in Shanghai, Jiangsu, and Zhejiang province. The Company also sells bulk products to institutional customers such as dairy and animal feed producers, as well as pharmaceutical companies. In February 2010, China-Biotics began its commercial production in China's largest probiotics production facility to meet growing demand in China. For more information, please visit http://www.chn-biotics.com .Contact:Travis Cai Chief Financial OfficerChina-Biotics, Inc.traviscai@chn-biotics.comShiwei Yin/Dixon Chen  Grayling646-284-9474shiwei.yin@grayling.com dixon.chen@grayling.com
'/>"/>

SOURCE China-Biotics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics to Report Fiscal Year 2011 Second Quarter Financial Results on November 9
2. China-Biotics Hosted its First Investor Day Event
3. China-Biotics Ranked Number 62 on FORTUNES 100 Fastest-Growing Companies List
4. China-Biotics to Report Fiscal Year 2011 First Quarter Financial Results on August 9
5. China-Biotics Provides Further Updates on Qingpu New Facility
6. China-Biotics, Inc. Reports Record Quarterly and Annual Revenue Growth for Fiscal Year 2010
7. China-Biotics to Report Fourth Quarter and Fiscal Year 2010 Financial Results on June 11
8. China-Biotics to Present at Bank of America Merrill Lynch Healthcare Event on June 22
9. China-Biotics Provides Updates on Qingpu New Facility and Chinese Probiotics Market
10. China-Biotics, Inc. Appointed Grayling as Strategic Investor Relations Advisor
11. China-Biotics, Inc. Inaugurated the Commercial Production of its New Production Facility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
(Date:6/23/2016)... NEW YORK , June, 23, 2016  The ... students to envision new ways to harness living systems ... of Modern Art (MoMA) in New York ... more than 130 participating students, showcased projects at MoMA,s ... included Paola Antonelli , MoMA,s senior curator of ...
(Date:6/23/2016)... NC (PRWEB) , ... June 23, 2016 , ... In ... University Hospital in Denmark detail how a patient who developed lymphedema after being treated ... tissue. The results could change the paradigm for dealing with this debilitating, frequent side ...
(Date:6/23/2016)... On Wednesday, June 22, 2016, the NASDAQ Composite ... Jones Industrial Average edged 0.27% lower to finish at 17,780.83; ... has initiated coverage on the following equities: Infinity Pharmaceuticals Inc. ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ), ... more about these stocks by accessing their free trade alerts ...
Breaking Biology Technology:
(Date:6/1/2016)... NEW YORK , June 1, 2016 ... Biometric Technology in Election Administration and Criminal Identification to ... According to a recently released TechSci Research report, " ... Sector, By Region, Competition Forecast and Opportunities, 2011 - ... $ 24.8 billion by 2021, on account of growing ...
(Date:5/20/2016)... , May 20, 2016  VoiceIt is excited ... with VoicePass. By working together, VoiceIt ...  Because VoiceIt and VoicePass take slightly different approaches ... increases both security and usability. ... about this new partnership. "This marketing ...
(Date:5/12/2016)... -- WearablesResearch.com , a brand of Troubadour Research ... the Q1 wave of its quarterly wearables survey. A ... to a program where they would receive discounts for ... "We were surprised to see that so ... , CEO of Troubadour Research, "primarily because there are ...
Breaking Biology News(10 mins):